Award
NIH Reporter #5R01CA281962-02
The Role and Therapeutic Targeting of GPR56 in Colorectal Cancer
Recipient
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
Award Amount
$406,611.00
Ceiling
$406,611.00
Awarded
April 21, 2026
Identifier
5R01CA281962-02
Research project awarded by the National Cancer Institute focusing on the role and therapeutic targeting of GPR56 in colorectal cancer, including antibody-drug conjugate development and disease mechanism studies.
Description
This project involves research on GPR56 in colorectal cancer, including development of antibody-drug conjugates and studying mechanisms of disease progression and resistance. The award is funded by the NIH/NCI with a focus on cancer therapeutics.